Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nitro derivatives as antiplatelet agents]

R De Caterina1

  • 1Istituto di Fisiologia Clinica, CNR, Pisa, Italia.

Cardiology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Nitrates, commonly used for ischemic heart disease, not only affect blood vessels but also inhibit platelet aggregation. This antiplatelet action may contribute to their protective effects against cardiac death and reinfarction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise pulmonary hypertension in asymptomatic patients with HIV infection Insights from the RIGHT-NET registry.

European journal of internal medicine·2026
Same author

Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.

International journal of cardiology·2026
Same author

Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2021
Same author

Impaired adenylate cyclase signaling in acute myocardial ischemia: Impact on effectiveness of P2Y<sub>12</sub> receptor antagonists.

Thrombosis research·2019
Same author

State of play and future direction with NOACs: An expert consensus.

Vascular pharmacology·2018
Same author

Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study.

European heart journal. Cardiovascular Imaging·2017

Area of Science:

  • Cardiovascular Pharmacology
  • Hemostasis and Thrombosis

Context:

  • Nitrates are a cornerstone therapy for ischemic heart disease.
  • Their primary therapeutic effects are attributed to vascular actions.

Purpose:

  • To explore the antiplatelet properties of nitrates.
  • To investigate the mechanisms and in vivo evidence of nitrate-induced platelet inhibition.

Summary:

  • Nitrates stimulate guanylate cyclase, increasing cyclic GMP levels, which inhibits platelet aggregation.
  • Evidence from ex vivo studies, prostacyclin synergism, sulfhydryl donor requirements, and bleeding time studies supports in vivo antiplatelet effects.
  • These antiplatelet effects may explain the observed reduction in cardiac death and reinfarction.

Impact:

Related Experiment Videos

  • Highlights a secondary mechanism of action for nitrates in cardiovascular disease.
  • Suggests a potential role for nitrates in preventing thrombotic events.
  • Provides a rationale for further research into nitrate antiplatelet activity and its clinical implications.